1. Home
  2. NFGC vs ITOS Comparison

NFGC vs ITOS Comparison

Compare NFGC & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NFGC
  • ITOS
  • Stock Information
  • Founded
  • NFGC 2016
  • ITOS 2011
  • Country
  • NFGC Canada
  • ITOS United States
  • Employees
  • NFGC N/A
  • ITOS N/A
  • Industry
  • NFGC Precious Metals
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NFGC Basic Materials
  • ITOS Health Care
  • Exchange
  • NFGC Nasdaq
  • ITOS Nasdaq
  • Market Cap
  • NFGC 226.7M
  • ITOS 270.7M
  • IPO Year
  • NFGC N/A
  • ITOS 2020
  • Fundamental
  • Price
  • NFGC $1.28
  • ITOS $6.67
  • Analyst Decision
  • NFGC Strong Buy
  • ITOS Strong Buy
  • Analyst Count
  • NFGC 1
  • ITOS 3
  • Target Price
  • NFGC $5.00
  • ITOS $25.67
  • AVG Volume (30 Days)
  • NFGC 775.5K
  • ITOS 559.5K
  • Earning Date
  • NFGC 05-16-2025
  • ITOS 04-28-2025
  • Dividend Yield
  • NFGC N/A
  • ITOS N/A
  • EPS Growth
  • NFGC N/A
  • ITOS N/A
  • EPS
  • NFGC N/A
  • ITOS N/A
  • Revenue
  • NFGC N/A
  • ITOS $35,000,000.00
  • Revenue This Year
  • NFGC N/A
  • ITOS N/A
  • Revenue Next Year
  • NFGC N/A
  • ITOS $31.74
  • P/E Ratio
  • NFGC N/A
  • ITOS N/A
  • Revenue Growth
  • NFGC N/A
  • ITOS 177.89
  • 52 Week Low
  • NFGC $0.93
  • ITOS $4.80
  • 52 Week High
  • NFGC $4.07
  • ITOS $18.75
  • Technical
  • Relative Strength Index (RSI)
  • NFGC 55.79
  • ITOS 49.00
  • Support Level
  • NFGC $1.07
  • ITOS $6.18
  • Resistance Level
  • NFGC $1.22
  • ITOS $7.80
  • Average True Range (ATR)
  • NFGC 0.07
  • ITOS 0.50
  • MACD
  • NFGC 0.03
  • ITOS -0.05
  • Stochastic Oscillator
  • NFGC 87.55
  • ITOS 29.94

About NFGC New Found Gold Corp

New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

Share on Social Networks: